Pharma: Other News To Note
Wednesday, October 10, 2012
Foundation Medicine Inc., of Cambridge, Mass., signed a multiyear agreement with Eisai Co. Ltd., of Tokyo, for genomic profiling and diagnostic discovery in a multisite, international clinical trial testing an Eisai therapeutic candidate.
Sign up for Perspectives FREE e-mail newsletter.
Outside the U.S.: 1-404-262-5423
Hours: Monday - Thursday, 8:30 am - 6:00 pm EST
Friday, 8:30am - 4:30 pm EST
Copyright @ 2013 AHC Media. Reproduction, reposting content is strictly prohibited.